Torrent Pharmaceuticals has announced a board meeting scheduled for February 13, 2026, to review and approve the audited financial results for the quarter and nine months ended December 31, 2025. The board will consider both standalone and consolidated financial results. Additionally, the board will deliberate on the payment of an interim dividend for the financial year 2025-26.
Upcoming Board Meeting
A meeting of the Board of Directors of Torrent Pharmaceuticals is scheduled to take place on February 13, 2026. The primary agenda is to review and approve the company’s financial performance.
Financial Results on the Agenda
During the meeting, the Board will consider and approve the audited financial results for the quarter and nine months which ended on December 31, 2025. This includes both standalone and consolidated financial statements.
Interim Dividend Consideration
The Board of Directors will also evaluate the possibility of declaring and paying an interim dividend for the financial year 2025-26.
Source: BSE
